文献速递复苏、休克与脓毒症

3区REBOA在非创伤性心脏骤停中不提供血流动力学益处

Zone 3 REBOA does not provide hemodynamic benefits during nontraumatic cardiac arrest.
PubMed 文献 · Am J Emerg Med · 2020-06-18
一句话结论猪室颤模型显示,3区REBOA相比无干预不改善舒张压,1区REBOA可改善舒张压但未提高ROSC率。

该研究为猪室颤心脏骤停模型,比较1区REBOA、3区REBOA与无干预对照对血流动力学的影响。机械CPR 5分钟后启动REBOA,持续记录30分钟。结果显示1区REBOA组舒张压显著高于对照组(19.9 mmHg vs 3.9 mmHg,p=.006),3区REBOA与对照无差异(p=.10),1区与3区之间也无差异(p=.10)。收缩压、脑血流和ROSC时间组间无显著差异。作者认为3区REBOA不提供血流动力学益处,REBOA可能对无血流时间延长的患者更有益。

要点

  • 猪室颤模型机械CPR 5分钟后启动REBOA,1区REBOA组舒张压中位数19.9 mmHg,显著高于对照组的3.9 mmHg(p=.006)。
  • 3区REBOA组舒张压中位数8.6 mmHg,与对照组3.9 mmHg相比无显著差异(p=.10),与1区组相比也无显著差异(p=.10)。
  • 收缩压、脑血流和ROSC时间在各组间均无显著差异。
  • 与既往研究不同,心脏骤停后立即使用REBOA未导致ROSC率增加。
  • 作者认为REBOA可能对无血流时间延长的患者更有益。

适用人群与场景

  • 猪室颤心脏骤停模型,麻醉后诱导室颤并立即开始机械CPR。

处置流程与药物剂量

  • 机械CPR开始5分钟后启动干预:1区REBOA、3区REBOA或无干预对照,血流动力学变量连续记录30分钟。

研究设计与关键结果

  • 研究类型为动物实验,15头猪随机分为1区REBOA、3区REBOA和对照三组。
  • REBOA置入前各组血流动力学无显著差异。
  • 1区REBOA组舒张压中位数19.9 mmHg(IQR 9.5-20.5)vs 对照组3.9 mmHg(IQR 2.4-4.8),p=.006。
  • 3区REBOA组舒张压中位数8.6 mmHg(IQR 5.1-13.1),与1区组比较p=.10,与对照组比较p=.10。
  • 收缩压、脑血流和ROSC时间组间无显著差异。

证据类型、等级与局限

  • 证据类型:动物实验(猪室颤模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在猪心脏骤停模型中,3区REBOA相比无阻断不提供血流动力学益处。
  • 作者认为,与既往研究不同,心脏骤停后立即使用REBOA未导致ROSC率增加,提示REBOA可能对无血流时间延长的患者更有益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) may be a novel intervention to improve cardiopulmonary resuscitation (CPR) quality during cardiac arrest. Zone 1 supraceliac aortic occlusion improves coronary and cerebral blood flow. It is unknown if Zone 3 occlusion distal to the renal arteries offers a similar physiologic benefit while maintaining blood flow to organs above the point of occlusion.

METHODS: Fifteen swine were anesthetized, instrumented, and placed into ventricular fibrillation. Mechanical CPR was immediately initiated. After 5 min of CPR, Zone 1 REBOA, Zone 3 REBOA, or no intervention (control) was initiated. Hemodynamic variables were continuously recorded for 30 min.

RESULTS: There were no significant differences between groups before REBOA deployment. Once REBOA was deployed, Zone 1 animals had statistically greater diastolic blood pressure compared to control (median [IQR]: 19.9 mmHg [9.5-20.5] vs 3.9 mmHg [2.4-4.8], p = .006). There were no differences in diastolic blood pressure between Zone 1 and Zone 3 (8.6 mmHg [5.1-13.1], p = .10) or between Zone 3 and control (p = .10). There were no significant differences in systolic blood pressure, cerebral blood flow, or time to return of spontaneous circulation (ROSC) between groups.

CONCLUSION: In our swine model of cardiac arrest, Zone 1 REBOA improved diastolic blood pressure when compared to control. Zone 3 does not offer a hemodynamic benefit when compared to no occlusion. Unlike prior studies, immediate use of REBOA after arrest did not result in an increase in ROSC rate, suggesting REBOA may be more beneficial in patients with prolonged no-flow time.

INSTITUTIONAL PROTOCOL NUMBER: FDG20180024A.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Nowadly CD, Hoareau GL, Grayson JK, et al. Zone 3 REBOA does not provide hemodynamic benefits during nontraumatic cardiac arrest. Am J Emerg Med. 2020. PMID: 32750628. doi:10.1016/j.ajem.2020.06.003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。